Overview
Daniel C. Brennan, M.D., joins the Johns Hopkins Division of Renal Medicine as professor of nephrology and medical director of the Comprehensive Transplant Center. Dr. Brennan’s areas of clinical expertise include transplant nephrology and renal disease. Prior to joining Johns Hopkins, Dr. Brennan was the Alan A. and Edith L. Wolff Professor of renal Diseases at Washington University and the Director of Transplant Nephrology at the Washington University School of Medicine. He received his undergraduate degree from Cornell College and earned his medical degree at the University of Iowa, where he completed a residency in internal medicine. He then completed research and clinical nephrology fellowships at Brigham & Women’s Hospital/Harvard Medical School. Dr. Brennan holds professional memberships at various organizations, including the American College of Physicians, the International Society of Nephrology, the American Society of Nephrology, The Transplantation Society, the American Society of Transplant Physicians and the American Society of Clinical Investigation.
Dr. Brennan is rated as an Experienced provider by MediFind in the treatment of Interstitial Nephritis. His top areas of expertise are Chronic Kidney Disease, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Kidney Transplant, and Pancreas Transplant.
His clinical research consists of co-authoring 223 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Interstitial Nephritis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 4, Floor 4, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Interstitial Nephritis. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.
JH Health Care & Surgery Center – White Marsh
Steven Menez is a Nephrologist in Nottingham, Maryland. Dr. Menez is rated as an Advanced provider by MediFind in the treatment of Interstitial Nephritis. His top areas of expertise are Interstitial Nephritis, Glomerulonephritis, Chronic Kidney Disease, Lupus Nephritis, and Kidney Transplant.
Johns Hopkins Outpatient Center
Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as a Distinguished provider by MediFind in the treatment of Interstitial Nephritis. His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Kidney DiseaseDr. Brennan isElite. Learn about Chronic Kidney Disease.
- Kidney TransplantDr. Brennan isElite. Learn about Kidney Transplant.
- Distinguished
- Cytomegalic Inclusion DiseaseDr. Brennan isDistinguished. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionDr. Brennan isDistinguished. Learn about Cytomegalovirus Infection.
- Advanced
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Chronic Antibody-Mediated RejectionDr. Brennan isAdvanced. Learn about Chronic Antibody-Mediated Rejection.
- D-Plus Hemolytic Uremic SyndromeDr. Brennan isAdvanced. Learn about D-Plus Hemolytic Uremic Syndrome.
- End-Stage Renal Disease (ESRD)Dr. Brennan isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Hemolytic-Uremic SyndromeDr. Brennan isAdvanced. Learn about Hemolytic-Uremic Syndrome.
- NephrectomyDr. Brennan isAdvanced. Learn about Nephrectomy.
- Experienced
- Acute Kidney FailureDr. Brennan isExperienced. Learn about Acute Kidney Failure.
- Fabry DiseaseDr. Brennan isExperienced. Learn about Fabry Disease.
- GlomerulonephritisDr. Brennan isExperienced. Learn about Glomerulonephritis.
- Interstitial NephritisDr. Brennan isExperienced. Learn about Interstitial Nephritis.
- Liddle SyndromeDr. Brennan isExperienced. Learn about Liddle Syndrome.
- Liver TransplantDr. Brennan isExperienced. Learn about Liver Transplant.